MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting

Reuters

2025/05/22

MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting

MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2537955718"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537955718\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537955718?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 03:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537955718","market":"us","top_or_hot":-1,"title":"MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-22 03:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2095319765.USD","symbol_name":"Natixis Thematics Subscription Economy R/A USD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL4YYWcs:1","article_id":"2537955718","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537955718","pubTimestamp":1747854915,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"MediPharm Labs Corp. , a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely infor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","NDAQ":"纳斯达克OMX交易所","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4585":"ETF&股票定投概念","BK4588":"碎股","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4112":"金融交易所和数据","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC"},"translate_title":"MediPharm Labs Corp.敦促股东通过绿色代理投票，在6月16日会议之前支持公司的提名人","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9},"content_text":"MediPharm Labs Corp. Urges Shareholders to Vote with GREEN Proxy, Supports Company's Nominees Ahead of June 16 Meeting\n    \n\n        MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9456050-en) on May 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}